Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey

Alvaro‐Lozano, Montserrat; Sandoval‐Ruballos, Mónica; Giovannini, Mattia; Jensen‐Jarolim, Erika; Şahiner, Ümit Murat; Spirić, Vesna Tomić; Quecchia, Cristina; Chaker, Adam; Heffler, Enrico; Klimek, Ludger; Brough, Helen A.; Sturm, Gunter J.; Untersmayr, Eva; Bonini, Matteo; Pfaar, Oliver

doi:10.1002/clt2.12097

Cited by 16 publications

(16 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to this analysis, respondents from university hospitals and maximum care hospitals as well as regional hospitals perceived significantly higher changes in their daily work due to the COVID‐19 pandemic than employees in the outpatient sector 24 . However, in another recently published survey by the EAACI aimed to evaluate real‐life consequences on the COVID‐19 pandemic in allergy practices in general, only 60% of the respondents informed about not‐changing prescriptions in venom immunotherapy 27 which again indicates to be below the results found in our survey.…”

Section: Discussioncontrasting

confidence: 91%

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

Pfaar

Hamelmann²,

Klimek

et al. 2022

Clinical & Translational All

Self Cite

View full text Add to dashboard Cite

Background: When the coronavirus pandemic 2019 (COVID-19) emerged, concerns were also raised regarding the safety of allergen immunotherapy (AIT). The German Society for Allergology and Clinical Immunology (DGAKI) conducted a survey to collect real-world data on the daily routine of administering subcutaneous AIT (SCIT) and sublingual AIT (SLIT) during the COVID-19 pandemic.Methods: A web-based retrospective survey using the online platform survio with 26 standardized questions was used to survey physicians treating allergic patients during the pandemic.Results: Three hundred and forty-five physicians who regularly offer and perform AIT in German-speaking countries responded to the questions. 70.4% of the respondents stated that they regularly initiated and dosed up SCIT for inhalant allergies (41.4% venom-SCIT, 73.6% SLIT), and 85.2% of the respondents stated that they continued SCIT for inhalant allergies during the maintenance phase in a regular way (59.1% venom-SCIT, 90.4% SLIT) in healthy patients without current symptoms indicating an infection with COVID-19. With regard to tolerability, there was no

show abstract

Section: Discussioncontrasting

confidence: 91%

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

Pfaar

Hamelmann²,

Klimek

et al. 2022

Clinical & Translational All

Self Cite

View full text Add to dashboard Cite

show abstract

“…This includes from basic elements to get started to more specific resources to further develop services (for instance, by systematically incorporating psychosocial and readiness assessment tools) or to signpost AYA or their families to good quality advice on a particular area (such as travelling or psychological support). The wider use of telemedicine and web‐based resources due to the COVID‐19 pandemic may provide opportunities for more convenient and effective interactions with AYA, and many of the resources selected can be used in this context 43,44 . We believe this pragmatic selection of resources is a great opportunity for all stakeholders, particularly HCP, to engage with transition to help meet AYA's needs and improve their long‐term health.…”

Section: Discussionmentioning

confidence: 99%

“…The wider use of telemedicine and web‐based resources due to the COVID‐19 pandemic may provide opportunities for more convenient and effective interactions with AYA, and many of the resources selected can be used in this context. 43 , 44 We believe this pragmatic selection of resources is a great opportunity for all stakeholders, particularly HCP, to engage with transition to help meet AYA's needs and improve their long‐term health. This would be equally helpful for AYA with complex multisystem allergic disease as well as AYA with less complex issues who may achieve good self‐management skills with a relatively simple transition approach supported by resources for non‐HCP presented in this work.…”

Section: Discussionmentioning

confidence: 99%

A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper

Vazquez‐Ortiz

Gore

Alviani

et al. 2022

Allergy

Self Cite

View full text Add to dashboard Cite

Adolescence is a challenging time for patients, their parents and their healthcare professionals (HCP). 1 Although Adolescent and Young Adult (AYA) patients are generally not seen as a vulnerable or 'in need' group, they have an unexpectedly high risk of morbidity and mortality. This includes a surprisingly high rate of asthma death and fatal anaphylaxis, which peaks in AYA. 2,3 The inclusion of adolescent health in the United Nations secretary general's Global Strategy for Women's and Children's Health in 2015 reflects a growing awareness of the importance and specificity of this stage of development. Adolescence is a critical stage of life characterized by rapid biological, emotional and social development, during which skills for a productive, healthy and satisfying life are developed. As part of this period of growth and development, the status of primary relationships and level of autonomy also shifts. The need to take on responsibility for behaviours and learn to cope with everyday events and challenges falls increasingly on the adolescent. 4 Together with these usual developmental tasks, adolescents with an allergic disease face additional challenges that may render them more vulnerable to adverse outcomes. This may include psychological issues (such as poor quality of life) and difficulties around adherence and self-management (such as risk-taking behaviours). These are common as AYA explore their boundaries and are influenced by peer pressure as parents 'let go'. They may include exposure to smoking, alcohol, other recreational drugs or food allergens in social contexts, which that may impact on their asthma control or risk of accidental exposures to foods. 1 Support is therefore vital for this age group. However, a recent European survey found that most HCP have not received training in how to support adolescents and young adults (AYA) with allergic conditions and do not have an established paediatric to adult healthcare transition process. 5 Ensuring that every adolescent has the knowledge and skills to self-manage their allergy with confidence is essential for achieving good mental and physical health and development goals and lower risk of adverse outcomes. This is equally necessary when patients stay within the same service as adults, as well as when they are transferred into an adult service, in which case the responsibility for an effective transition is shared by the paediatric and adult teams.The European Academy of Allergy and Clinical Immunology (EAACI) transition guideline was developed by a multi-stakeholder Task Force from across Europe using evidence-based principles and published to support HCP in effectively managing AYA. 4 Its recommendations have been favourably reviewed by AYA and parents from across Europe. 6 This paper aimed to provide HCP (both paediatric and adult, as well as those seeing all ages), AYA and families with practical and targeted resources to support successful selfmanagement of asthma and allergic conditions.

show abstract

“…Although general recommendations suggest the continuation of allergen immunotherapy and biological therapy, the discontinuation rate is significant in some countries. 9,[80][81][82][83] Websites offering episodic on-demand care may disrupt the continuity of healthcare between the patient and the allergist and undermine care coordination. In-person consultations are a preferred option for severe allergic conditions.…”

Section: Disadvantages Of Tm For Allergic Patientsmentioning

confidence: 99%

Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper

Smolinska,

Popescu,

Izquierdo

et al. 2023

Allergy

Self Cite

View full text Add to dashboard Cite

Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID‐19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face‐to‐face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.

show abstract

Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey

Cited by 16 publications

References 53 publications

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper

Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper

Contact Info

Product

Resources

About